Summary of all the Indicators
Overall Consensus
Strong Buy
15Bullish
4Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Halozyme Therapeutics’s (RV7) Moving Averages Convergence Divergence (MACD) indicator is 2.81, suggesting Halozyme Therapeutics is a Buy.
Halozyme Therapeutics’s (RV7) 20-Day exponential moving average is 91.71, while Halozyme Therapeutics’s (RV7) share price is €92.62, making it a Buy.
Halozyme Therapeutics’s (RV7) 50-Day exponential moving average is 84.49, while Halozyme Therapeutics’s (RV7) share price is €92.62, making it a Buy.
Halozyme (RV7) Pivot Points
Classic
91.00
91.38
92.14
92.52
93.28
93.66
94.42
Fibonacci
91.38
91.82
92.08
92.52
92.96
93.22
93.66
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Halozyme (RV7) Moving Averages
MA5
93.45Buy
93.86Buy
MA10
93.43Buy
93.34Buy
MA20
92.94Buy
91.71Buy
MA50
82.84Buy
84.49Buy
MA100
71.90Buy
76.41Buy
MA200
65.26Buy
69.39Buy
Halozyme Therapeutics’s (RV7) 10-Day exponential moving average is 93.34, while Halozyme Therapeutics’s (RV7) share price is €92.62, making it a Buy.
Halozyme Therapeutics’s (RV7) 100-Day exponential moving average is 76.41, while Halozyme Therapeutics’s (RV7) share price is €92.62, making it a Buy.
Halozyme Therapeutics’s (RV7) stock price is €92.62 and Halozyme Therapeutics’s (RV7) 50-day simple moving average is 82.84, creating a Buy signal.
Halozyme Therapeutics’s (RV7) stock price is €92.62 and Halozyme Therapeutics’s (RV7) 100-day simple moving average is 71.90, creating a Buy signal.
Halozyme Therapeutics’s (RV7) stock price is €92.62 and Halozyme Therapeutics’s (RV7) 200-day simple moving average is 65.26, creating a Buy signal.
Halozyme (RV7) Technical Indicators
RSI (14)
70.67
Sell
STOCH (9,6)
49.32
Neutral
STOCHRSI (14)
60.22
Neutral
MACD (12,26)
2.81
Buy
ADX (14)
39.90
Neutral
Williams %R
-2.87
Sell
CCI (14)
151.30
Sell
ATR (14)
1.50
-
Ultimate Oscillator
65.69
Neutral
ROC
5.55
Buy
Halozyme Therapeutics’s (RV7) Relative Strength Index (RSI) is 70.67, creating a Sell signal.
Halozyme Therapeutics’s (RV7) Trend Strength Indicator (ADX) is 39.90, creating a Neutral signal.
Halozyme Therapeutics’s (RV7) Commodity Channel Index (CCI) is 151.30, creating a Sell signal.
Halozyme Therapeutics’s (RV7) Price Rate of Change (ROC) is 5.55, creating a Buy signal.
FAQ
Is RV7 a Buy, Hold, or Sell?
Based on RV7’s technical indicators, RV7 is a Strong Buy.
What is RV7’s RSI (14)?
RV7’s RSI (14) is 70.67, which suggests RV7 is a Sell.
What is RV7’s MACD?
RV7’s MACD is 2.81, which suggests RV7 is a Buy.
What is RV7’s 5-day moving average?
RV7’s 5-day moving average is 93.45, which suggests RV7 is a Buy.
What is RV7’s 20-day moving average?
RV7 20-day moving average is 92.94, which suggests RV7 is a Buy.
What is RV7’s 50-day moving average?
RV7’s 50-day moving average is 82.84, which suggests RV7 is a Buy.
What is RV7’s 200-day moving average?
RV7’s 200-day moving average is 65.26, which suggests RV7 is a Buy.
What is RV7’s Williams % R (14)?
RV7’s Williams % R (14) is -2.87, which suggests RV7 is a Sell.
What is RV7’s CCI (14)?
RV7’s CCI (14) is 151.30, which suggests RV7 is a Sell.
What is the share price of Halozyme Therapeutics?
Halozyme's share price is N/A€.